As Executive Vice President for Health Sciences at Georgetown University and Executive Dean of the School of Medicine, Howard Federoff oversees a biomedical research organization with $138 million in external research funding in 2005.

He is responsible for advancing the educational and research missions of Georgetown University Medical Center (GUMC).

Prior to his arrival at Georgetown, Dr. Federoff held appointments as Senior Associate Dean for Basic Research; Professor of Neurology, Medicine Microbiology and Immunology; and Professor of Oncology and Genetics at the University of Rochester School of Medicine, and as Founding Director of the Center for Aging and Development Biology at the Aab Institution of Biomedical Sciences at Rochester.

After joining the Rochester faculty in 1995, he also served as Director of the University of Rochester’s Interdepartmental Neuroscience Program and as Founding Chief of the Division of Molecular Medicine and Gene Therapy.

Dr. Federoff’s research interests include gene therapy and neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and prion diseases. His research has received support from the National Science Foundation, the National Institutes of Health (NIH), and the U.S. Department of Defense, among other sources.

He has published widely in peer-reviewed journals, and currently serves on the editorial boards of five such journals, including Brain and Mind, Experimental Neurology, and Gene Therapy. In 2006, Dr. Federoff was named Chair of the NIH Recombinant DNA Advisory Committee.